|
Tabla 2: Proporciones agrupadas de resistencia a los antibióticos para Staphylococcus aureus. |
||||||
|
Resistencia % |
General N = 742 n (%) |
2020 N = 144 n (%) |
2021 N = 156 n (%) |
2022 N = 203 n (%) |
2023 N = 168 n (%) |
2024 N = 71 n (%) |
|
Ciprofloxacino |
168 (22.6) |
26 (18.1) |
41 (26.3) |
52 (25.6) |
37 (22.0) |
12 (16.9) |
|
Gentamicina |
223 (30.1) |
40 (27.8) |
56 (35.9) |
61 (30.0) |
47 (28.0) |
19 (26.8) |
|
Levofloxacino |
158 (21.3) |
22 (15.3) |
31 (19.9) |
52 (25.6) |
43 (25.6) |
10 (14.1) |
|
Trimetoprima sulfametoxazol |
107 (14.4) |
24 (16.7) |
20 (12.8) |
30 (14.8) |
28 (16.7) |
5 (7.0) |
|
Tetraciclina |
107 (14.4) |
16 (11.1) |
26 (16.7) |
27 (13.3) |
23 (13.7) |
15 (21.1) |
|
Cefoxitina |
229 (30.9) |
13 (9.7) |
42 (26.9) |
127 (62.6) |
41 (24.4) |
5 (7.0) |
|
Clindamicina |
245 (33.0) |
48 (33.3) |
38 (24.4) |
69 (34.0) |
58 (34.5) |
32 (45.1) |
|
Eritromicina |
358 (48.2) |
66 (45.8) |
74 (47.4) |
99 (48.8) |
81 (48.2) |
38 (53.5) |
|
Oxacilina |
268 (36.1) |
55 (38.2) |
57 (36.5) |
66 (32.5) |
69 (41.1) |
21 (29.6) |
|
Vancomicina |
102 (13.7) |
13 (9.0) |
30 (19.2) |
30 (14.8) |
18 (10.7) |
11 (15.5) |
|
Daptomicina |
120 (16.2) |
22 (15.3) |
34 (21.8) |
30 (14.8) |
22 (13.1) |
12 (16.9) |
|
Penicilina |
109 (14.7) |
22 (15.3) |
34 (21.8) |
30 (14.8) |
14 (8.3) |
9 (12.7) |
|
Linezolid |
125 (16.8) |
26 (18.1) |
44 (28.2) |
30 (14.8) |
18 (10.7) |
7 (9.9) |
|
Rifampicina |
71 (9.6) |
11 (7.6) |
17 (10.9) |
17 (8.4) |
22 (13.1) |
4 (5.6) |